Genentech

HERCEPTIN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Herceptin HCPCS:

J9355

HCPCS Code Descriptor:

Injection, trastuzumab, excludes biosimilar, 10 mg

Category:

J Code

Herceptin NDCs:

50242-0132-10, 50242-0132-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Herceptin CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

50242-0132-10

About Herceptin:

HERCEPTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9355 is aligned to the drug HERCEPTIN.

ACCESS PRICING AND MORE BY REGISTERING

J9355 Added Date:

January 1, 2000

J9355 Effective Date:

July 1, 2019

J9355 Termination Date:

HCPCS Active

Our team has not identified a manufacturer source of billing and coding information for HERCEPTIN
Herceptin patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
HERCEPTIN prescribing information can be found at the link below:
Information regarding HERCEPTIN’s side effects can be found at MedlinePlus